Navigating Antitrust Issues in the Life Sciences Industry

Navigating Antitrust Issues in the Life Sciences Industry

Speaking Engagement CLE

Biotechnology, pharmaceutical, diagnostic and medical device companies at various stages often encounter potential antitrust issues arising from brand-generic competition, patent litigation and settlements, life cycle management strategies, sales practices, M&A, and other transformative transactions including licensing and competitor collaborations. In this webinar, lawyers from WilmerHale’s leading Life Sciences Practice will provide an overview of antitrust principles followed by an in-depth discussion on industry developments and considerations for in-house counsel and executives navigating these risks.

View the Webinar Recording*

*CLE credit is not available for those who watch webinar recordings.

Read More About the Event



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.